Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Medexus Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2030 | $182.39M | $161.24M - $200.17M | $12.93M | $1.223 | 1 |
| Mar 2029 | $163.00M | $144.10M - $178.90M | $11.56M | $1.00 | 3 |
| Mar 2028 | $140.09M | $123.84M - $153.75M | $9.93M | $0.63 | 4 |
| Mar 2027 | $114.54M | $101.26M - $125.71M | $8.12M | $0.246 | 6 |
| Mar 2026 | $100.06M | $99.46M - $100.99M | $7.09M | $0.004 | 6 |
| Mar 2025 | $109.35M | $106.91M - $112.95M | $7.75M | $0.035 | 7 |
| Mar 2024 | $79.57M | $70.34M - $87.32M | $5.64M | $0.034 | 6 |
| Mar 2023 | $107.59M | $100.54M - $113.05M | $8.10M | -$0.331 | 5 |
| Mar 2022 | $75.13M | $70.20M - $78.93M | $5.65M | -$0.12 | 2 |
| Mar 2021 | $86.51M | $80.84M - $90.89M | $6.51M | -$1.106 | 3 |
| Mar 2020 | $51.09M | $47.74M - $53.68M | $3.85M | -$0.172 | 5 |
| Mar 2019 | $25.10M | $23.45M - $26.37M | $1.89M | -$0.475 | 2 |